CA2035603C - A method of detecting the presence of anomalies exfoliated cells using infrared spectroscopy - Google Patents
A method of detecting the presence of anomalies exfoliated cells using infrared spectroscopyInfo
- Publication number
- CA2035603C CA2035603C CA 2035603 CA2035603A CA2035603C CA 2035603 C CA2035603 C CA 2035603C CA 2035603 CA2035603 CA 2035603 CA 2035603 A CA2035603 A CA 2035603A CA 2035603 C CA2035603 C CA 2035603C
- Authority
- CA
- Canada
- Prior art keywords
- specimen
- cells
- exfoliated
- infrared
- functional group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000004566 IR spectroscopy Methods 0.000 title claims abstract description 9
- 238000000034 method Methods 0.000 title claims description 19
- 238000010521 absorption reaction Methods 0.000 claims abstract description 19
- 125000000524 functional group Chemical group 0.000 claims abstract description 15
- 150000002632 lipids Chemical class 0.000 claims abstract description 13
- 150000001720 carbohydrates Chemical class 0.000 claims abstract description 12
- 235000014633 carbohydrates Nutrition 0.000 claims abstract description 12
- 102000039446 nucleic acids Human genes 0.000 claims abstract description 12
- 108020004707 nucleic acids Proteins 0.000 claims abstract description 12
- 150000007523 nucleic acids Chemical class 0.000 claims abstract description 12
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 9
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 9
- 150000004713 phosphodiesters Chemical group 0.000 claims abstract description 8
- 229910014033 C-OH Inorganic materials 0.000 claims description 7
- 229910014570 C—OH Inorganic materials 0.000 claims description 7
- 239000012528 membrane Substances 0.000 claims description 3
- 238000010183 spectrum analysis Methods 0.000 claims description 3
- 210000004291 uterus Anatomy 0.000 claims description 3
- 210000000416 exudates and transudate Anatomy 0.000 abstract description 9
- 210000000056 organ Anatomy 0.000 abstract description 5
- 238000007790 scraping Methods 0.000 abstract description 5
- 230000028327 secretion Effects 0.000 abstract description 5
- 230000001680 brushing effect Effects 0.000 abstract description 4
- 238000009595 pap smear Methods 0.000 abstract description 4
- 230000002159 abnormal effect Effects 0.000 abstract 2
- 210000004027 cell Anatomy 0.000 description 50
- 210000001519 tissue Anatomy 0.000 description 47
- 230000003211 malignant effect Effects 0.000 description 24
- 238000012360 testing method Methods 0.000 description 12
- 238000002329 infrared spectrum Methods 0.000 description 9
- 230000002380 cytological effect Effects 0.000 description 8
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 8
- 238000001228 spectrum Methods 0.000 description 8
- 206010028980 Neoplasm Diseases 0.000 description 7
- 201000011510 cancer Diseases 0.000 description 7
- 229920002527 Glycogen Polymers 0.000 description 6
- 229940096919 glycogen Drugs 0.000 description 6
- 206010058314 Dysplasia Diseases 0.000 description 5
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 4
- 206010008342 Cervix carcinoma Diseases 0.000 description 3
- 201000010881 cervical cancer Diseases 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 210000002919 epithelial cell Anatomy 0.000 description 3
- 230000036210 malignancy Effects 0.000 description 3
- 230000003595 spectral effect Effects 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 239000000232 Lipid Bilayer Substances 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 238000005452 bending Methods 0.000 description 2
- 210000001072 colon Anatomy 0.000 description 2
- 230000000112 colonic effect Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 210000004379 membrane Anatomy 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 238000012935 Averaging Methods 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 208000031662 Noncommunicable disease Diseases 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 208000005448 Trichomonas Infections Diseases 0.000 description 1
- 208000002495 Uterine Neoplasms Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 210000000621 bronchi Anatomy 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 210000003679 cervix uteri Anatomy 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 210000002726 cyst fluid Anatomy 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000000834 fixative Substances 0.000 description 1
- 230000000762 glandular Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 210000004969 inflammatory cell Anatomy 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000009878 intermolecular interaction Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000005170 neoplastic cell Anatomy 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- 108091005981 phosphorylated proteins Proteins 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 238000002271 resection Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 210000001179 synovial fluid Anatomy 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 210000001635 urinary tract Anatomy 0.000 description 1
- 206010046766 uterine cancer Diseases 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
- 238000011121 vaginal smear Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
- G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
- G01N21/35—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light
Landscapes
- Physics & Mathematics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The presence of anomalies is detected in exfoliated cells (e.g. in a cervical smear) using infrared spectroscopy. A beam of infrared light is directed at specimens containing cells, which may be secretions, exudates, transudates, scrapings, brushings or otherwise obtained populations of exfoliated cells of various organs or tissues, and the anomaly is detected at at least one range of frequencies by determining whether changes in infrared absorption has occurred which is due to functional group vibration in, for example, phosphodiester groups of nucleic acids, COH groups of tissue proteins, carbohydrates, or due to special arrangements of lipid molecules or abnormal lipid structure, present in the specimen.
The presence of anomalies is detected in exfoliated cells (e.g. in a cervical smear) using infrared spectroscopy. A beam of infrared light is directed at specimens containing cells, which may be secretions, exudates, transudates, scrapings, brushings or otherwise obtained populations of exfoliated cells of various organs or tissues, and the anomaly is detected at at least one range of frequencies by determining whether changes in infrared absorption has occurred which is due to functional group vibration in, for example, phosphodiester groups of nucleic acids, COH groups of tissue proteins, carbohydrates, or due to special arrangements of lipid molecules or abnormal lipid structure, present in the specimen.
The presence of anomalies is detected in exfoliated cells (e.g. in a cervical smear) using infrared spectroscopy. A beam of infrared light is directed at specimens containing cells, which may be secretions, exudates, transudates, scrapings, brushings or otherwise obtained populations of exfoliated cells of various organs or tissues, and the anomaly is detected at at least one range of frequencies by determining whether changes in infrared absorption has occurred which is due to functional group vibration in, for example, phosphodiester groups of nucleic acids, COH groups of tissue proteins, carbohydrates, or due to special arrangements of lipid molecules or abnormal lipid structure, present in the specimen.
Description
X ~ 3 3 ~ ~1 3 '~_ l This invention relates to a method of detecting the presence of anomalies in exfoliated cells using infrared spectroscopy.
It is well known that examination for characteristic neoplastic cells in exfoliated tissue or cell specimens from, for example, the secretions, exudates, transudates, scrapings or brushings from various human organs or tissues may permit the diagnosis of malignancy. Exfoliative cytology has been found to be so valuable in the detection of early cancer of the uterus and uterine cervix that it is usually performed as a routine part of the annual examination for all adult women, see Pathologic Examination, Enfoliative Cytologic Study, Chapter 24, pages 362-365.
Exfoliated tissue or cell specimens may also be obtained from, for example, the trachea and bronchi, stomach, rectum and colon, urinary tract, serous sac fluids, cyst fluids, synovial fluids, glandular secretions and exudates. Methods for obtaining, collecting and, if necessary, preserving the specimens may vary according to the preference.
Each collected specimen is spread intact as an even layer over a clean microscope slide and submerged in, for example, an alcohol-ether fixative for about one hour.
After being fixed, and without being allowed to dry, the layer is coated with glycerin and the whole sandwiched between two glass slides. The slides are then sent to a laboratory for staining and microscopic diagnosis by trained and experienced pathologists or cytologists.
~ O } ~
_ 2 1 While the microscopic diagnosis of exfoliated tissue or cell specimens is useful, the diagnostic interpretation:
i) has to be carried out by skilled personnel, ii) is not completely reliable due, for example, to abundant mucous, trichomonas infection or atrophy, and iii) cannot accurately detect, for example, malignancy in tissues or cells in the pre-malignant or early malignant stages.
There is a need for a method of detecting the presence of anomalies in exfoliated cells wherein:
i) a simple test on the specimen, and the interpretation thereof, can be carried out by personnel having no medical skills and after a relatively brief course of training, ii) with proper care, interpretation of the test results is reliable, and iii) malignancy in tissues or cells can be detected in the pre-malignant or early malignant stages.
It has already been proposed in the applicants' co-pending Canadian Patent Application No. 2,008,831-1, filed January 29, 1990, "Method of Detecting the Presence of Anomalies in Biological Tissues and Cells in Natural or Cultured Form by Infrared Spectroscopy", P.T.T. Wong and B.
Rigas, to detect the presence of anomalies in biological tissues and cells in natural and cultured form (e.g.
cancerous tissues or cells) by infrared spectroscopy. A
~35~3 _ 3 1 beam of infrared light is directed at a sample of tissue or cells in natural or cultured form containing the cells to be tested, and the anomaly is detected at at least one range of frequencies by determining whether changes in infrared absorption have occurred due to the vibration of at least one functional group of molecules present in the sample which is characteristic of the anomaly.
The method taught by P.T.T. Wong and B. Rigas is applied in the examples to biopsed tissue or cultured cells.
In particular, P.T.T. Wong and B. Rigas, page 7, line 20 to page 8, line 36, teach the detection of colorectal cancer from colonic mucosa immediately following bowel resection, i.e. colonic mucous membrane immediately following surgical removal of a section or segment of the bowel.
It has now been found, according to the present invention, that detection of the presence of anomalies in exfoliated cells by spectral analysis of the infrared absorption characteristics of the cells is possible. Mucin, water, inorganic salts, epithelial cells, red blood cells and leukocytes of the fluid do not give rise to any spurious interpretation of the infrared spectral absorption characteristics of the cells.
According to the present invention there is provided a method of detecting the presence of anomalies in exfoliated cells using infrared spectroscopy, comprising:
a) directing a beam of infrared light at a specimen of exfoliated cells, and ~-~3~ ~3 ~_ 4 l b) determining if an anomaly is present in the specimen by spectral analysis of the infrared absorption of the specimen, at at least one range of frequencies, to ascertain whether at least one change in the infrared absorption characteristics has occurred, due to vibration of at least one functional group of molecules, in the specimen, which is characteristic of that anomaly.
The said at least one change in the infrared absorption characteristics may be a change in absorption intensity at a particular frequency, a change of frequency at which a particular absorption occurs, or a different pressure applied to the functional group causing a change of frequency at which a particular absorption occurs.
The functional group of molecules may be in at least one of the following molecules, carbohydrates, nucleic acids, tissue proteins or membrane lipids.
The functional group may be a phosphodiester group in nucleic acids, a C-OH group in tissue protein and carbohydrates, or a CH2 group in lipids.
The functional group may be at least one functional group selected from the groups consisting of carbohydrates, phosphodiester groups in nucleic acids, COH groups of tissue proteins or carbohydrates and CH2 group of lipids.
The specimen may be a Papanicolau smear.
The specimen may be a cervical specimen.
The specimen may be an endocervical specimen.
The specimen may be an ectocervical specimen.
~V~ 03 ~ 5 1 The specimen may be a vaginal specimen.
The specimen may be a uterus specimen.
In the accompanying drawings which illustrate, by way of example, embodiments of the present invention, Figure 1 is a block diagram of an apparatus for detecting the presence of anomalies in exfoliated cells using infrared spectroscopy, Figure 2 shows infrared spectra in the frequency range 950 to 1,350 cm-l, obtained from normal healthy, exfoliated cervical cell specimens designated ---- and from exfoliated cervical cell specimens designated and diagnosed in a conventional, cytological manner as malignant, Figures 3 to 5 show the frequency shifts of the infrared bands at ~1082 cm 1, and ~1155 cm-l, and the changes in the intensity ratios between the infrared bands at ~1025 cm 1 and ~ 1082 cm 1, respectively, between healthy, exfoliated cervical cell specimens and those diagnosed in a conventional, cytological manner as malignant, Figure 6 shows the infrared spectra depicted in Figure 2, for the bands at ~1240 cm-l, enlarged and superimposed, Figure 7 shows the corresponding third power derivative spectra of the infrared spectra depicted in Figure 2 for the bands in the frequency region 1190 to 1275 cm 1, Figure 8 shows a comparison of the pressure 6 ,~03~603 " _ 1 dependencies of the vibrational frequencies of P02 groups of nucleic acids in exfoliated cells of cervical tissues, Figure 9 is an enlargement of the infrared bands in the frequency region 1140 cm-l to 1185 cm-l between normal, healthy exfoliated cervical cell specimens and those diagnosed in a conventional, cytological manner as malignant, Figure 10 shows the corresponding third power derivative spectra of the infrared spectra shown in Figure 9, Figure 11 shows a comparison of the pressure dependancies of the frequencies of the component bands of the C-0 stretching modes in the frequency range 1140 cm 1 to 1190 cm 1 between normal, healthy, exfoliated cervical tissue specimens and those diagnosed in a conventional, cytological manner as malignant, Figure 12 shows a comparison of the pressure dependancies of the CH2 bending modes of the methylene chains in membrane lipids between normal exfoliated cervical tissue specimens and those diagnosed in a conventional, cytological manner as malignant, Figure 13 shows a comparison of the infrared spectra in the frequency range 950 cm 1 to 1350 cm 1 for exfoliated cervical specimens diagnosed in a conventional, cytological manner as normal, malignant and dysplasia, and Figure 14 shows infrared spectra in the frequency range 950 to 1,350 cm 1, obtained from healthy, exfoliated '~ 7 203~03 1 vaginal cell specimens and those diagnosed in a conventional, cytological manner as malignant.
Referring now to Figure 1, there is shown an infrared source ], a lens 2, a sample cell and holder 4, an infrared spectrometer 6, a computer 8 and a readout 10.
In operation, an exfoliated tissue or cell specimen is placed in the sample cell and holder 4 and a beam of infrared light from the source 1 which has been condensed by the lens 2, is passed through the sample in the sample cell and holder 4. Any infrared absorption by the specimen is detected by the infrared spectrometer 6, which in turn is computed by the computer to give a readout at the readout 10. The computer readout may be arranged to directly indicate whether the specimen is a normal, healthy one or one which contains an anomaly (i.e. benign, dysplasia or malignant).
In tests to verify the present invention, infrared (IR) spectra were obtained as described with reference to Fig. 1 from exfoliated cervical cell specimens, that were collected from 25 females undergoing a surveillance Papanicolaou test (cervical cytology) following a standard "scraping" or "brushing" procedure. These specimens consisted of epithelial cells, inflammatory cells, red blood cells and bacteria that are part of the normal flora. The tests indicated that non-epithelial cells, present in varying numbers in all specimens and semiquantitated by two independent observers, did not influence the infrared ~0336~3 1 spectra to any significant extent in the spectral regions under study; hemolysis of the red cells studied in control specimens did not significantly alter the infrared spectra either in the spectral region under study.
In further tests, cells from exfoliated scrapings obtained with a brush, were harvested by gently shaking the brush in a normal saline solution. Two halves of this cell suspension were separately pelleted by centrifugation.
Following removal of the supernatant, one pellet was frozen in liquid nitrogen, to be studied later spectroscopically for IR absorption, according to the present invention, while aliquots of the other pellet were spread on microscope slides, fixed and stained with Papanicolaou stain and diagnosed in the conventional manner. Each sample was rated independently by two experienced physicians, and there was complete agreement between these ratings. Infrared absorption spectra were obtained as previously described with reference to Figure 1. Cells were smeared on the sample holderi the spectroscopic patterns were stable for many hours following sample application. An auto scale plotting configuration device was set to automatically normalize peak intensities.
The tests made fell into two groups, which were i) atmospheric pressure tests, where the sample holder described and claimed in United States Patent No.
4,980,551, dated Dece~ber 25, 1990, was found to be useful, and 203~03 ., g 1 ii) high pressure tests, where the sample holder described and claimed in United States Patent No. 4,970,396, dated November 13, 1990, was found to be useful.
Cervical specimens rated as normal healthy specimens on the basis of conventional, cytological evaluation displayed essentially identical IR spectra. The spectra of specimens diagnosed cytologically as malignant were markedly different from those of normal specimens. In Figure 2 the results for normal healthy cervical tissue are shown ---- , and the results for malignant cervical tissue are shown these are typical spectra from normal healthy and malignant cervical specimens. The most prominent differences include the following findings in malignant specimens:
a) severe change in the intensity of the bands at ~1025 cm-l, ~ 1047 cm-l (it appears as a shoulder on ~ 1025 cm 1 band), ~ 1082 cm 1, ~ 1155 cm 1, ~ 1244 cm 1 and ~1303 cm 1, b) significant shift of ~ 1082 cm 1, ~ 1155 cm 1 and ~-1244 cm 1 peaks, and c) a new band peaking at ~ 970 cm 1.
In Figures 3 to 5, 0 are the results for normal healthy exfoliated cervical tissue and 8 are the results for malignant, exfoliated cells of cervical tissue. The shifts in the two peaks at ~ 1082 cm 1 and ~ 1155 cm 1 averaging about 4 and 12 wave numbers, respectively, for all the specimens studied are shown in Figures 3 and 9. Figure 5 shows that the ratio of the peak intensity between the --~03~03 ,"". ,.
1 1025 cm 1 and ~ 1082 cm 1 bands differs greatly between normal and cancer tissue specimens.
The bands at ~ 1025 cm 1 and ~ 1047 cm 1 were found to be due to carbohydrates, and glycogen was found to make an overwhelming contribution to the intensity of these bands. The bands at ~ 1082 cm 1 and ~ 1244 cm 1 were found to be due to the symmetric and asymmetric phosphate (P02-) stretching modes, respectively. They were found to originate mainly in the vibrations of the phosphodiester groups of cellular nucleic acids. The band at ~ 1155 cm-l was found to be due to the C-O stretching mode of the C-OH groups of, among others, the residues of the amino acids serine, threonine and tyrosine in cell proteins as well as the C-OH groups of carbohydrates. The band at -1303 cm 1 consists of many overlapping bands and its assignment has yet to be confirmed. Finally, the band at --970 cm 1 was found to be due partly to the vibrational mode of dianionic phosphate groups, as had been previously observed in the infrared spectra of model phosphorylated proteins, and partly due to DNA and/or RNA molecules.
Referring now to Figure 6, which is an enlargement of a portion of Figure 2, and the corresponding third power derivative spectra shown in Figure 7, a more detailed study of the asymmetric phosphate stretching band revealed that in malignant, exfoliated cervical tissues, shown , it consisted of two overlapping bands, one of which, the lower frequency band, was markedly increased when -compared to 203~fi~3 1 normal healthy, exfoliated cells. The frequency of the asymmetric P02 stretching band was known at the time that the tests were made to be ~ 1220 cm 1, when the P02 group was fully hydrogen-bonded, and greater than ~ 1240 cm 1 when it is not hydrogen-bonded. This finding indicated that in cervical cancer many P02 groups of nucleic acids are hydrogen-bonded, in contrast to those of the normal, exfoliated cervical tissue. This conclusion is supported further by the pressure dependence of the frequencies of these bands, as shown in Figure 8, where O
shows the results for normal healthy, exfoliated cervical tissue and O the results for cancerous, exfoliated cervical tissue. The frequency of the low-frequency band was found to decrease with increasing pressure, whereas that of the high-frequency band of cancer and ~he single PO~, band of normal healthy tissue were found to lncrease with increasing pressure. This response of the low-frequency band to pressure is known to be typical of a hydrogen-bonded group because pressure enhances the strength of hydrogen bonds and thereby decreases the frequency of the P02 stretching. On the other hand, the effect of pressure on the high-frequency P02 band, common to malignant and normal tissue, is known to be characteristic of non-hydrogen bonded functional groups and results from pressure enhancement of intermolecular interactions.
A similar analysis of the C-O stretching band at 1155 cm 1, shown in Figures 9 and 10 where the results for 203~
1 normal, healthy, exfoliated cells of cervical tissue are shown ---- and the results for cancerous, exfoliated cells of cervical tissue are shown , revealed that it consists of three overlapping bands, ~ 1153 cm 1, ~ 1161 cm~l and ~1172 cm-l of which the first two display decreased intensity and the third increased intensity when compared to the corresponding bands of normal cervical tissue.
The fFequencies of the first two decrease with increasing pressure, whereas that of the latter was found to increase as shown in Figure 11. These findings, therefore, indicate that the component bands at ~ 1153 cm 1 and ~ 1161 cm 1 arise from the stretching vibrations of hydrogen-bonded C-OH groups, whereas the band at ~ 1172 cm 1 is due to the stretching vibrations of non hydrogen-bonded C-OH
groups.
In Figure 12, where O shows the results for normal, healthy, exfoliated cells of cervical tissue and 0 shows the results for cancerous, exfoliated cells of cervical tissue, the pressure dependence of the frequency of the CH2 bending mode of the methylene chains of lipids is shown in the frequency range 1466 cm 1 to 1476 cm 1 The pressure dependence in the frequency of this band has previously been widely used to study interchain p~cking and order/disorder properties of lipid bilayers. In lipid bilayers pressure was found to produce an increase in the frequency of this band because induced conformational and ~3~3 ~_ 13 1 orientational ordering of the methylene chains occurred, which thereby increase interchain interactions. In malignant cervical tissue, pressure was found to induce a smaller shift in this frequency range as compared to normal healthy tissue. This indicates that in exfoliated cells of cervical cancer tissue the methylene chains of lipids are more disordered than in normal, healthy, exfoliated cells of cervical tissue.
In Figure 13, the results for normal, healthy, exfoliated cervical specimens are shown ----, for dysplasia are shown ----, and for malignant specimens are shown In Figure 13, the prominent differences for dysplasia specimens as compared to normal specimens, include:
a) severe change in the intensity of the bands at ~ 1025 cm 1, ~ 1082 cm 1, ~ 1244 cm 1 and ~ 1303 cm 1, and b) a significant shift in the frequency of the bands at ~ 1047 cm 1 and ~ 1082 cm 1 Also in Figure 13, the prominent differences for malignant specimens as compared to normal and dysplasia specimens include:
a) severe change in the intensity of the bands at ~ 970 cm-l, ~ 1025 cm 1, ~ 1047 cm 1, ~ 1082 cm 1, ~ 1155 cm 1, ~ 1244 cm 1 and ~ 1303 cm 1, and b) a si~nificant shift in the frequency of the bands at ~3~3 _ 14 1 ~ 1025 cm-l, ~ 1047 cm-l, ~ 1082 cm-l and ~ 1155 These tests indicated that several important changes are associated with cervical, exfoliated cancer tissue. The amount of glycogen was found dramatically decreased in exfoliated, cervical cells of cancer tissue as compared to normal, healthy, exfoliated cells of cervical tissue. This is further confirmed by the fact that cancer of the liver, an organ extremely rich in glycogen, displays a similar spectroscopic pattern which is not observed in cancer of the colon, an intestinal portion poor in glycogen.
The known spectrum of glycogen (D-glycogen from mammalian liver) is comparable with that obtained by the applicants in the frequence region ~ ~75-1100 cm 1 (Figures 13 and 14).
Furthermore, the hydrogen-bonding of the phosphodiester groups of nucleic acids was found to increase in exfoliated cells of cervical cancer tissue. This spectroscopic finding was common to those found in other tests with cancerous tissue biopsied specimens that the applicants had examined such as colon, liver, skin, vagina and breast.
In Figure 14, the results for healthy vaginal specimens are shown ----, while those for malignant specimens are shown In Figure 14, the prominent differences for the malignant specimens as compared to normal specimens include:
2103~03 1 a) a severe change in the intensity of the bands at ~1025 cm 1, ~ 1154 cm~1, ~ 1240 cm 1 and ~1300 cm-l, and b) a significant shift in the frequency of the bands at ~ 1025cm 1, ~ 1155 cm 1 and ~ 1081 cm 1 These and other tests have indicated that the present invention is useful for, for example, detecting anomalies in exfoliated tissue or cell specimens from secretions, exudates, transudates of various human or other mammalian organs or tissues, and is particularly useful for detecting exfoliated cancerous tissues or cells from Papanicolaou cervical smears, i.e., endocervical smears, ectocervical smears-, vaginal smears and uterus smears.
Exfoliated cell anomalies which ~ay be detected according to the present invention include, for example, viruses, bacteria, fungi and other infections and non-infectious diseases.
The cell anomalies may be detected in exfoliated cells or in cells in exfoliated tissue.
It is well known that examination for characteristic neoplastic cells in exfoliated tissue or cell specimens from, for example, the secretions, exudates, transudates, scrapings or brushings from various human organs or tissues may permit the diagnosis of malignancy. Exfoliative cytology has been found to be so valuable in the detection of early cancer of the uterus and uterine cervix that it is usually performed as a routine part of the annual examination for all adult women, see Pathologic Examination, Enfoliative Cytologic Study, Chapter 24, pages 362-365.
Exfoliated tissue or cell specimens may also be obtained from, for example, the trachea and bronchi, stomach, rectum and colon, urinary tract, serous sac fluids, cyst fluids, synovial fluids, glandular secretions and exudates. Methods for obtaining, collecting and, if necessary, preserving the specimens may vary according to the preference.
Each collected specimen is spread intact as an even layer over a clean microscope slide and submerged in, for example, an alcohol-ether fixative for about one hour.
After being fixed, and without being allowed to dry, the layer is coated with glycerin and the whole sandwiched between two glass slides. The slides are then sent to a laboratory for staining and microscopic diagnosis by trained and experienced pathologists or cytologists.
~ O } ~
_ 2 1 While the microscopic diagnosis of exfoliated tissue or cell specimens is useful, the diagnostic interpretation:
i) has to be carried out by skilled personnel, ii) is not completely reliable due, for example, to abundant mucous, trichomonas infection or atrophy, and iii) cannot accurately detect, for example, malignancy in tissues or cells in the pre-malignant or early malignant stages.
There is a need for a method of detecting the presence of anomalies in exfoliated cells wherein:
i) a simple test on the specimen, and the interpretation thereof, can be carried out by personnel having no medical skills and after a relatively brief course of training, ii) with proper care, interpretation of the test results is reliable, and iii) malignancy in tissues or cells can be detected in the pre-malignant or early malignant stages.
It has already been proposed in the applicants' co-pending Canadian Patent Application No. 2,008,831-1, filed January 29, 1990, "Method of Detecting the Presence of Anomalies in Biological Tissues and Cells in Natural or Cultured Form by Infrared Spectroscopy", P.T.T. Wong and B.
Rigas, to detect the presence of anomalies in biological tissues and cells in natural and cultured form (e.g.
cancerous tissues or cells) by infrared spectroscopy. A
~35~3 _ 3 1 beam of infrared light is directed at a sample of tissue or cells in natural or cultured form containing the cells to be tested, and the anomaly is detected at at least one range of frequencies by determining whether changes in infrared absorption have occurred due to the vibration of at least one functional group of molecules present in the sample which is characteristic of the anomaly.
The method taught by P.T.T. Wong and B. Rigas is applied in the examples to biopsed tissue or cultured cells.
In particular, P.T.T. Wong and B. Rigas, page 7, line 20 to page 8, line 36, teach the detection of colorectal cancer from colonic mucosa immediately following bowel resection, i.e. colonic mucous membrane immediately following surgical removal of a section or segment of the bowel.
It has now been found, according to the present invention, that detection of the presence of anomalies in exfoliated cells by spectral analysis of the infrared absorption characteristics of the cells is possible. Mucin, water, inorganic salts, epithelial cells, red blood cells and leukocytes of the fluid do not give rise to any spurious interpretation of the infrared spectral absorption characteristics of the cells.
According to the present invention there is provided a method of detecting the presence of anomalies in exfoliated cells using infrared spectroscopy, comprising:
a) directing a beam of infrared light at a specimen of exfoliated cells, and ~-~3~ ~3 ~_ 4 l b) determining if an anomaly is present in the specimen by spectral analysis of the infrared absorption of the specimen, at at least one range of frequencies, to ascertain whether at least one change in the infrared absorption characteristics has occurred, due to vibration of at least one functional group of molecules, in the specimen, which is characteristic of that anomaly.
The said at least one change in the infrared absorption characteristics may be a change in absorption intensity at a particular frequency, a change of frequency at which a particular absorption occurs, or a different pressure applied to the functional group causing a change of frequency at which a particular absorption occurs.
The functional group of molecules may be in at least one of the following molecules, carbohydrates, nucleic acids, tissue proteins or membrane lipids.
The functional group may be a phosphodiester group in nucleic acids, a C-OH group in tissue protein and carbohydrates, or a CH2 group in lipids.
The functional group may be at least one functional group selected from the groups consisting of carbohydrates, phosphodiester groups in nucleic acids, COH groups of tissue proteins or carbohydrates and CH2 group of lipids.
The specimen may be a Papanicolau smear.
The specimen may be a cervical specimen.
The specimen may be an endocervical specimen.
The specimen may be an ectocervical specimen.
~V~ 03 ~ 5 1 The specimen may be a vaginal specimen.
The specimen may be a uterus specimen.
In the accompanying drawings which illustrate, by way of example, embodiments of the present invention, Figure 1 is a block diagram of an apparatus for detecting the presence of anomalies in exfoliated cells using infrared spectroscopy, Figure 2 shows infrared spectra in the frequency range 950 to 1,350 cm-l, obtained from normal healthy, exfoliated cervical cell specimens designated ---- and from exfoliated cervical cell specimens designated and diagnosed in a conventional, cytological manner as malignant, Figures 3 to 5 show the frequency shifts of the infrared bands at ~1082 cm 1, and ~1155 cm-l, and the changes in the intensity ratios between the infrared bands at ~1025 cm 1 and ~ 1082 cm 1, respectively, between healthy, exfoliated cervical cell specimens and those diagnosed in a conventional, cytological manner as malignant, Figure 6 shows the infrared spectra depicted in Figure 2, for the bands at ~1240 cm-l, enlarged and superimposed, Figure 7 shows the corresponding third power derivative spectra of the infrared spectra depicted in Figure 2 for the bands in the frequency region 1190 to 1275 cm 1, Figure 8 shows a comparison of the pressure 6 ,~03~603 " _ 1 dependencies of the vibrational frequencies of P02 groups of nucleic acids in exfoliated cells of cervical tissues, Figure 9 is an enlargement of the infrared bands in the frequency region 1140 cm-l to 1185 cm-l between normal, healthy exfoliated cervical cell specimens and those diagnosed in a conventional, cytological manner as malignant, Figure 10 shows the corresponding third power derivative spectra of the infrared spectra shown in Figure 9, Figure 11 shows a comparison of the pressure dependancies of the frequencies of the component bands of the C-0 stretching modes in the frequency range 1140 cm 1 to 1190 cm 1 between normal, healthy, exfoliated cervical tissue specimens and those diagnosed in a conventional, cytological manner as malignant, Figure 12 shows a comparison of the pressure dependancies of the CH2 bending modes of the methylene chains in membrane lipids between normal exfoliated cervical tissue specimens and those diagnosed in a conventional, cytological manner as malignant, Figure 13 shows a comparison of the infrared spectra in the frequency range 950 cm 1 to 1350 cm 1 for exfoliated cervical specimens diagnosed in a conventional, cytological manner as normal, malignant and dysplasia, and Figure 14 shows infrared spectra in the frequency range 950 to 1,350 cm 1, obtained from healthy, exfoliated '~ 7 203~03 1 vaginal cell specimens and those diagnosed in a conventional, cytological manner as malignant.
Referring now to Figure 1, there is shown an infrared source ], a lens 2, a sample cell and holder 4, an infrared spectrometer 6, a computer 8 and a readout 10.
In operation, an exfoliated tissue or cell specimen is placed in the sample cell and holder 4 and a beam of infrared light from the source 1 which has been condensed by the lens 2, is passed through the sample in the sample cell and holder 4. Any infrared absorption by the specimen is detected by the infrared spectrometer 6, which in turn is computed by the computer to give a readout at the readout 10. The computer readout may be arranged to directly indicate whether the specimen is a normal, healthy one or one which contains an anomaly (i.e. benign, dysplasia or malignant).
In tests to verify the present invention, infrared (IR) spectra were obtained as described with reference to Fig. 1 from exfoliated cervical cell specimens, that were collected from 25 females undergoing a surveillance Papanicolaou test (cervical cytology) following a standard "scraping" or "brushing" procedure. These specimens consisted of epithelial cells, inflammatory cells, red blood cells and bacteria that are part of the normal flora. The tests indicated that non-epithelial cells, present in varying numbers in all specimens and semiquantitated by two independent observers, did not influence the infrared ~0336~3 1 spectra to any significant extent in the spectral regions under study; hemolysis of the red cells studied in control specimens did not significantly alter the infrared spectra either in the spectral region under study.
In further tests, cells from exfoliated scrapings obtained with a brush, were harvested by gently shaking the brush in a normal saline solution. Two halves of this cell suspension were separately pelleted by centrifugation.
Following removal of the supernatant, one pellet was frozen in liquid nitrogen, to be studied later spectroscopically for IR absorption, according to the present invention, while aliquots of the other pellet were spread on microscope slides, fixed and stained with Papanicolaou stain and diagnosed in the conventional manner. Each sample was rated independently by two experienced physicians, and there was complete agreement between these ratings. Infrared absorption spectra were obtained as previously described with reference to Figure 1. Cells were smeared on the sample holderi the spectroscopic patterns were stable for many hours following sample application. An auto scale plotting configuration device was set to automatically normalize peak intensities.
The tests made fell into two groups, which were i) atmospheric pressure tests, where the sample holder described and claimed in United States Patent No.
4,980,551, dated Dece~ber 25, 1990, was found to be useful, and 203~03 ., g 1 ii) high pressure tests, where the sample holder described and claimed in United States Patent No. 4,970,396, dated November 13, 1990, was found to be useful.
Cervical specimens rated as normal healthy specimens on the basis of conventional, cytological evaluation displayed essentially identical IR spectra. The spectra of specimens diagnosed cytologically as malignant were markedly different from those of normal specimens. In Figure 2 the results for normal healthy cervical tissue are shown ---- , and the results for malignant cervical tissue are shown these are typical spectra from normal healthy and malignant cervical specimens. The most prominent differences include the following findings in malignant specimens:
a) severe change in the intensity of the bands at ~1025 cm-l, ~ 1047 cm-l (it appears as a shoulder on ~ 1025 cm 1 band), ~ 1082 cm 1, ~ 1155 cm 1, ~ 1244 cm 1 and ~1303 cm 1, b) significant shift of ~ 1082 cm 1, ~ 1155 cm 1 and ~-1244 cm 1 peaks, and c) a new band peaking at ~ 970 cm 1.
In Figures 3 to 5, 0 are the results for normal healthy exfoliated cervical tissue and 8 are the results for malignant, exfoliated cells of cervical tissue. The shifts in the two peaks at ~ 1082 cm 1 and ~ 1155 cm 1 averaging about 4 and 12 wave numbers, respectively, for all the specimens studied are shown in Figures 3 and 9. Figure 5 shows that the ratio of the peak intensity between the --~03~03 ,"". ,.
1 1025 cm 1 and ~ 1082 cm 1 bands differs greatly between normal and cancer tissue specimens.
The bands at ~ 1025 cm 1 and ~ 1047 cm 1 were found to be due to carbohydrates, and glycogen was found to make an overwhelming contribution to the intensity of these bands. The bands at ~ 1082 cm 1 and ~ 1244 cm 1 were found to be due to the symmetric and asymmetric phosphate (P02-) stretching modes, respectively. They were found to originate mainly in the vibrations of the phosphodiester groups of cellular nucleic acids. The band at ~ 1155 cm-l was found to be due to the C-O stretching mode of the C-OH groups of, among others, the residues of the amino acids serine, threonine and tyrosine in cell proteins as well as the C-OH groups of carbohydrates. The band at -1303 cm 1 consists of many overlapping bands and its assignment has yet to be confirmed. Finally, the band at --970 cm 1 was found to be due partly to the vibrational mode of dianionic phosphate groups, as had been previously observed in the infrared spectra of model phosphorylated proteins, and partly due to DNA and/or RNA molecules.
Referring now to Figure 6, which is an enlargement of a portion of Figure 2, and the corresponding third power derivative spectra shown in Figure 7, a more detailed study of the asymmetric phosphate stretching band revealed that in malignant, exfoliated cervical tissues, shown , it consisted of two overlapping bands, one of which, the lower frequency band, was markedly increased when -compared to 203~fi~3 1 normal healthy, exfoliated cells. The frequency of the asymmetric P02 stretching band was known at the time that the tests were made to be ~ 1220 cm 1, when the P02 group was fully hydrogen-bonded, and greater than ~ 1240 cm 1 when it is not hydrogen-bonded. This finding indicated that in cervical cancer many P02 groups of nucleic acids are hydrogen-bonded, in contrast to those of the normal, exfoliated cervical tissue. This conclusion is supported further by the pressure dependence of the frequencies of these bands, as shown in Figure 8, where O
shows the results for normal healthy, exfoliated cervical tissue and O the results for cancerous, exfoliated cervical tissue. The frequency of the low-frequency band was found to decrease with increasing pressure, whereas that of the high-frequency band of cancer and ~he single PO~, band of normal healthy tissue were found to lncrease with increasing pressure. This response of the low-frequency band to pressure is known to be typical of a hydrogen-bonded group because pressure enhances the strength of hydrogen bonds and thereby decreases the frequency of the P02 stretching. On the other hand, the effect of pressure on the high-frequency P02 band, common to malignant and normal tissue, is known to be characteristic of non-hydrogen bonded functional groups and results from pressure enhancement of intermolecular interactions.
A similar analysis of the C-O stretching band at 1155 cm 1, shown in Figures 9 and 10 where the results for 203~
1 normal, healthy, exfoliated cells of cervical tissue are shown ---- and the results for cancerous, exfoliated cells of cervical tissue are shown , revealed that it consists of three overlapping bands, ~ 1153 cm 1, ~ 1161 cm~l and ~1172 cm-l of which the first two display decreased intensity and the third increased intensity when compared to the corresponding bands of normal cervical tissue.
The fFequencies of the first two decrease with increasing pressure, whereas that of the latter was found to increase as shown in Figure 11. These findings, therefore, indicate that the component bands at ~ 1153 cm 1 and ~ 1161 cm 1 arise from the stretching vibrations of hydrogen-bonded C-OH groups, whereas the band at ~ 1172 cm 1 is due to the stretching vibrations of non hydrogen-bonded C-OH
groups.
In Figure 12, where O shows the results for normal, healthy, exfoliated cells of cervical tissue and 0 shows the results for cancerous, exfoliated cells of cervical tissue, the pressure dependence of the frequency of the CH2 bending mode of the methylene chains of lipids is shown in the frequency range 1466 cm 1 to 1476 cm 1 The pressure dependence in the frequency of this band has previously been widely used to study interchain p~cking and order/disorder properties of lipid bilayers. In lipid bilayers pressure was found to produce an increase in the frequency of this band because induced conformational and ~3~3 ~_ 13 1 orientational ordering of the methylene chains occurred, which thereby increase interchain interactions. In malignant cervical tissue, pressure was found to induce a smaller shift in this frequency range as compared to normal healthy tissue. This indicates that in exfoliated cells of cervical cancer tissue the methylene chains of lipids are more disordered than in normal, healthy, exfoliated cells of cervical tissue.
In Figure 13, the results for normal, healthy, exfoliated cervical specimens are shown ----, for dysplasia are shown ----, and for malignant specimens are shown In Figure 13, the prominent differences for dysplasia specimens as compared to normal specimens, include:
a) severe change in the intensity of the bands at ~ 1025 cm 1, ~ 1082 cm 1, ~ 1244 cm 1 and ~ 1303 cm 1, and b) a significant shift in the frequency of the bands at ~ 1047 cm 1 and ~ 1082 cm 1 Also in Figure 13, the prominent differences for malignant specimens as compared to normal and dysplasia specimens include:
a) severe change in the intensity of the bands at ~ 970 cm-l, ~ 1025 cm 1, ~ 1047 cm 1, ~ 1082 cm 1, ~ 1155 cm 1, ~ 1244 cm 1 and ~ 1303 cm 1, and b) a si~nificant shift in the frequency of the bands at ~3~3 _ 14 1 ~ 1025 cm-l, ~ 1047 cm-l, ~ 1082 cm-l and ~ 1155 These tests indicated that several important changes are associated with cervical, exfoliated cancer tissue. The amount of glycogen was found dramatically decreased in exfoliated, cervical cells of cancer tissue as compared to normal, healthy, exfoliated cells of cervical tissue. This is further confirmed by the fact that cancer of the liver, an organ extremely rich in glycogen, displays a similar spectroscopic pattern which is not observed in cancer of the colon, an intestinal portion poor in glycogen.
The known spectrum of glycogen (D-glycogen from mammalian liver) is comparable with that obtained by the applicants in the frequence region ~ ~75-1100 cm 1 (Figures 13 and 14).
Furthermore, the hydrogen-bonding of the phosphodiester groups of nucleic acids was found to increase in exfoliated cells of cervical cancer tissue. This spectroscopic finding was common to those found in other tests with cancerous tissue biopsied specimens that the applicants had examined such as colon, liver, skin, vagina and breast.
In Figure 14, the results for healthy vaginal specimens are shown ----, while those for malignant specimens are shown In Figure 14, the prominent differences for the malignant specimens as compared to normal specimens include:
2103~03 1 a) a severe change in the intensity of the bands at ~1025 cm 1, ~ 1154 cm~1, ~ 1240 cm 1 and ~1300 cm-l, and b) a significant shift in the frequency of the bands at ~ 1025cm 1, ~ 1155 cm 1 and ~ 1081 cm 1 These and other tests have indicated that the present invention is useful for, for example, detecting anomalies in exfoliated tissue or cell specimens from secretions, exudates, transudates of various human or other mammalian organs or tissues, and is particularly useful for detecting exfoliated cancerous tissues or cells from Papanicolaou cervical smears, i.e., endocervical smears, ectocervical smears-, vaginal smears and uterus smears.
Exfoliated cell anomalies which ~ay be detected according to the present invention include, for example, viruses, bacteria, fungi and other infections and non-infectious diseases.
The cell anomalies may be detected in exfoliated cells or in cells in exfoliated tissue.
Claims (11)
1. A method of detecting the presence of anomalies in exfoliated cells using infrared spectroscopy, comprising:
a) directing a beam of infrared light at a specimen of exfoliated cells, and b) determining if an anomaly is present in the specimen by spectral analysis of the infrared absorption by the specimen, at at least one range of frequencies, to ascertain whether at least one change in the infrared absorption characteristics has occurred, due to vibration of at least one functional group of molecules, present in the specimen, which is characteristic of that anomaly.
a) directing a beam of infrared light at a specimen of exfoliated cells, and b) determining if an anomaly is present in the specimen by spectral analysis of the infrared absorption by the specimen, at at least one range of frequencies, to ascertain whether at least one change in the infrared absorption characteristics has occurred, due to vibration of at least one functional group of molecules, present in the specimen, which is characteristic of that anomaly.
2. A method according to claim 1, wherein the said at least one change in the infrared absorption characteristics is a change in absorption intensity at a particular frequency, a change of frequency at which a particular absorption occurs, or a different pressure applied to the functional group causing a change of frequency at which a particular absorption occurs.
3. A method according to claim 1, wherein the functional group of molecules is in at least one of the following molecules, carbohydrates, nucleic acids, tissue proteins or membrane lipids.
4. A method according to claim 1, wherein the functional group is a phosphodiester group in nucleic acids, a C-OH
group in tissue protein and carbohydrates, or a CH2 group in lipids.
group in tissue protein and carbohydrates, or a CH2 group in lipids.
5. A method according to claim 1, wherein the functional group of molecules is in at least one of the following:
carbohydrates, phosphodiester groups in nucleic acids, C-OH groups of tissue proteins and carbohydrates, or CH2 group of lipids.
carbohydrates, phosphodiester groups in nucleic acids, C-OH groups of tissue proteins and carbohydrates, or CH2 group of lipids.
6. A method according to claim 1, wherein the specimen is a Papanicolau smear.
7. A method according to claim 1, wherein the specimen is a cervical specimen.
8. A method according to claim 1, wherein the specimen is an endocervical specimen.
9. A method according to claim 1, wherein the specimen is an ectocervical specimen.
10. A method according to claim 1, wherein the specimen is a vaginal specimen.
11. A method according to claim 1, wherein the specimen is a uterus specimen.
Priority Applications (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA 2035603 CA2035603C (en) | 1991-02-04 | 1991-02-04 | A method of detecting the presence of anomalies exfoliated cells using infrared spectroscopy |
| US07/656,508 US5168162A (en) | 1991-02-04 | 1991-02-19 | Method of detecting the presence of anomalies in exfoliated cells using infrared spectroscopy |
| AU11808/92A AU1180892A (en) | 1991-02-04 | 1992-01-31 | A method of detecting the presence of anomalies in exfoliated cells using infrared spectroscopy |
| EP92903692A EP0570418A1 (en) | 1991-02-04 | 1992-01-31 | A method of detecting the presence of anomalies in exfoliated cells using infrared spectroscopy |
| JP4503235A JPH06507237A (en) | 1991-02-04 | 1992-01-31 | A method for detecting the presence of abnormalities in exfoliated cells using infrared spectroscopy |
| PCT/CA1992/000030 WO1992014134A1 (en) | 1991-02-04 | 1992-01-31 | A method of detecting the presence of anomalies in exfoliated cells using infrared spectroscopy |
| CN92101432A CN1067314A (en) | 1991-02-04 | 1992-02-04 | Detect in the cell be stripped from infrared spectrum and to have unusual method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA 2035603 CA2035603C (en) | 1991-02-04 | 1991-02-04 | A method of detecting the presence of anomalies exfoliated cells using infrared spectroscopy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2035603A1 CA2035603A1 (en) | 1992-08-05 |
| CA2035603C true CA2035603C (en) | 1998-08-04 |
Family
ID=4146947
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA 2035603 Expired - Fee Related CA2035603C (en) | 1991-02-04 | 1991-02-04 | A method of detecting the presence of anomalies exfoliated cells using infrared spectroscopy |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP0570418A1 (en) |
| JP (1) | JPH06507237A (en) |
| CN (1) | CN1067314A (en) |
| AU (1) | AU1180892A (en) |
| CA (1) | CA2035603C (en) |
| WO (1) | WO1992014134A1 (en) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5733739A (en) * | 1995-06-07 | 1998-03-31 | Inphocyte, Inc. | System and method for diagnosis of disease by infrared analysis of human tissues and cells |
| WO1997014961A1 (en) * | 1995-10-18 | 1997-04-24 | Aktsionernoe Obschestvo Zakrytogo Tipa 'ntf Intersvyaz' | Method of diagnosing malignant disorders |
| AUPN825796A0 (en) * | 1996-02-26 | 1996-03-14 | Ashdown, Martin | The application of infrared (ir) spectrometry to the investigations of components of blood and other body fluids |
| US6214550B1 (en) | 1997-06-27 | 2001-04-10 | Pacific Northwest Research Institute | Methods of differentiating metastatic and non-metastatic tumors |
| JP4403908B2 (en) * | 2004-07-27 | 2010-01-27 | 住友電気工業株式会社 | Peptide or protein phosphorylation analyzer, phosphorylation discrimination program, and recording medium for the program |
| RU2012157998A (en) | 2010-06-01 | 2014-07-20 | Тодос Медикал Лтд. | CANCER DIAGNOSTICS |
| US9719937B2 (en) | 2011-05-11 | 2017-08-01 | Todos Medical Ltd. | Diagnosis of cancer |
| EP3489659B1 (en) | 2013-05-28 | 2021-03-03 | Todos Medical Ltd. | A method of indicating the presence of benign tumors using a peripheral blood mononuclear cells (pbmc) sample |
| KR101735464B1 (en) | 2014-12-17 | 2017-05-15 | 한밭대학교 산학협력단 | Device for detecting organic material and measuring death rate of cells, and method thereof |
| GB2545877B (en) * | 2015-09-10 | 2021-09-15 | Sierra Medical Ltd | ATR-FTIR computational analysis of Barrett's esophagus and esophageal cancers |
| JP2017203637A (en) * | 2016-05-09 | 2017-11-16 | 住友電気工業株式会社 | Tumor cell detection method and tumor cell detection device |
| CN110702720A (en) * | 2019-10-09 | 2020-01-17 | 李俊菲 | Sampling swab and collection set for gynecological secretion analyzer |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4017192A (en) * | 1975-02-06 | 1977-04-12 | Neotec Corporation | Optical analysis of biomedical specimens |
| DE3903777A1 (en) * | 1989-02-09 | 1990-08-16 | Bruker Analytische Messtechnik | METHOD FOR THE QUICK DETECTION OF MICROORGANISMS IN SAMPLES AND DEVICE FOR IMPLEMENTING THE METHOD |
| US4970396A (en) * | 1989-12-26 | 1990-11-13 | National Research Council Of Canada/Conseil National De Recherches Du Canada | Infrared spectra recording, high pressure sample holder |
| US4980551A (en) * | 1990-01-05 | 1990-12-25 | National Research Council Canada Conseil National De Recherches Canada | Non-pressure-dependancy infrared absorption spectra recording, sample cell |
| CA2008831C (en) * | 1990-01-29 | 1996-03-26 | Patrick T.T. Wong | Method of detecting the presence of anomalies in biological tissues and cells in natural and cultured form by infrared spectroscopy |
-
1991
- 1991-02-04 CA CA 2035603 patent/CA2035603C/en not_active Expired - Fee Related
-
1992
- 1992-01-31 JP JP4503235A patent/JPH06507237A/en active Pending
- 1992-01-31 AU AU11808/92A patent/AU1180892A/en not_active Abandoned
- 1992-01-31 WO PCT/CA1992/000030 patent/WO1992014134A1/en not_active Application Discontinuation
- 1992-01-31 EP EP92903692A patent/EP0570418A1/en not_active Withdrawn
- 1992-02-04 CN CN92101432A patent/CN1067314A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU1180892A (en) | 1992-09-07 |
| JPH06507237A (en) | 1994-08-11 |
| CA2035603A1 (en) | 1992-08-05 |
| EP0570418A1 (en) | 1993-11-24 |
| WO1992014134A1 (en) | 1992-08-20 |
| CN1067314A (en) | 1992-12-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5168162A (en) | Method of detecting the presence of anomalies in exfoliated cells using infrared spectroscopy | |
| Chiriboga et al. | Infrared spectroscopy of human tissue. I. Differentiation and maturation of epithelial cells in the human cervix | |
| Ci et al. | Fourier transform infrared spectroscopic characterization of human breast tissue: implications for breast cancer diagnosis | |
| CA2035603C (en) | A method of detecting the presence of anomalies exfoliated cells using infrared spectroscopy | |
| Fung et al. | Comparison of Fourier-transform infrared spectroscopic screening of exfoliated cervical cells with standard Papanicolaou screening | |
| CA2008831C (en) | Method of detecting the presence of anomalies in biological tissues and cells in natural and cultured form by infrared spectroscopy | |
| Wong et al. | Infrared spectra of microtome sections of human colon tissues | |
| ES2438093T3 (en) | Reconstitution method of cell spectra useful for detecting cell disorders | |
| Wong et al. | Characterization of exfoliated cells and tissues from human endocervix and ectocervix by FTIR and ATR/FTIR spectroscopy | |
| EP1978867B1 (en) | Methods for characterizing tissues | |
| CA2483420A1 (en) | Bio-spectral imaging system and methods for diagnosing cell disease state | |
| AU2011333336B2 (en) | Methods and kits for differential staining of abnormal urinary system cells | |
| US20050250091A1 (en) | Raman molecular imaging for detection of bladder cancer | |
| Böcking et al. | Towards a single cell cancer diagnosis. Multimodal and monocellular measurements of markers and morphology (5M) | |
| CN1474175B (en) | Super fine optical spectrum imaging instrument or system | |
| Zhang et al. | Application and Progress of Raman Spectroscopy in Male Reproductive System | |
| JPH10505412A (en) | Infrared spectroscopy of preservative treated samples | |
| Sunder et al. | Laser Raman spectroscopy: A novel diagnostic tool for oral cancer | |
| Grable et al. | Nuclear size of cells in normal stomachs, in gastric atrophy and in gastric cancer | |
| SU1114004A1 (en) | Method of diagnostics of degree of malignization in case of fibrous-cystoid mastopathy | |
| RU2092843C1 (en) | Method of differential diagnosis of fibroadenoma and mamma cancer | |
| RU2235323C2 (en) | Method of diagnosing malignant tumors | |
| RU2127429C1 (en) | Method of diagnosing hyperplastic processes and endometrium cancer | |
| Peresunko et al. | Spectropolarimetry differential diagnosis of adenocarcinoma and squamous cell cervix carcinoma | |
| Naik et al. | I. Normal Vulvar Epithelium and Epithelium Adjacent to Vulvar Intraepithelial Neoplasia and Squamous Cell Carcinoma |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |